ARS Pharmaceuticals, Inc. (SPRY) vs Tectonic Therapeutic, Inc. (TECX)
- ARS Pharmaceuticals, Inc. SPRY 4.02 −1.23%
- Tectonic Therapeutic, Inc. TECX 20.65 −3.05%
ARS Pharmaceuticals, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. ARS Pharmaceuticals, Inc. and Tectonic Therapeutic, Inc. are of similar size ($416.4M and $404.8M). Tectonic Therapeutic, Inc. has the higher net margin (0.00% vs −184.3%) and the higher return on invested capital (0.00% vs −335.7%). Across the 14 metrics below, Tectonic Therapeutic, Inc. leads on 12 and ARS Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | SPRY | TECX | Biotechnology median |
|---|---|---|---|
| Gross margin | 71.37% | 0.00% | 65.16% |
| Operating margin | (184.96%) | 0.00% | 0.00% |
| Net margin | (184.26%) | 0.00% | 0.00% |
| Free cash flow margin | (167.97%) | 0.00% | 0.00% |
| Return on equity | (210.37%) | (33.80%) | (56.36%) |
| Return on assets | (76.54%) | (32.23%) | (48.04%) |
| Return on invested capital | (335.65%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack